do glp-1 agonists have cardiovascular benefit Bridging the gap between GLP1-receptor and outcomes: evidence for the role of tirzepatide | Cardiovascular Diabetology do glp-1 agonists have cardiovascular

Description

In a public advisory on Wednesday, Health Canada said that as interest grows in GLP-1 products for weight loss, "some people may turn to unauthorized or counterfeit products, which could pose serious health risks because they have not been assessed by Health Canada for safety, effectiveness, or quality." The versions of the medications authorized for use in Canada are semaglutide (Ozempic and Wegovy injections and Rybelsus oral tablets) and tirzepatide (Mounjaro and Zepbound injections)

Saxenda is sometimes prescribed off-label for metabolic dysfunction-associated steatohepatitis (MASH)

TimmersLHenriquesJPde KleijnDPDevriesJHKempermanHSteendijkPet alExenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury